Infliximab-Induced Psoriaform Rash

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 10, 2010, Pages

  Goldstein, Jonathan ^a   Levine, Joel ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; MERCAPTOPURINE;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; FEMALE; HUMAN; PSORIASIS;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; EXANTHEMA; FEMALE; HUMANS; SKIN;

EID: 77957164871     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.04.015     Document Type: Article

References (5)

1. Wollina U., Hansel G., Koch A., et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008, 9:1-14.
2. Sari I., Akar S., Birlik M., et al. Anti-tumor necrosis factor-alpha-induced psoriasis. J Rheumatol 2006, 33:1411-1414.
3. Fiorino G., Allez M., Malesci A., et al. Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009, 29:921-927.
4. Cuchacovich R., Espinoza C.G., Virk Z., et al. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha?. J Clin Rheumatol 2008, 14:353-356.
5. Seneschal J., Milpied B., Vergier B., et al. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 2009, 161:1081-1088.